-
Mashup Score: 2
Financial toxicity is an increasing problem for patients with gynecologic cancer. Our analysis, using objective measures of financial toxicity, has suggested that demographic factors and healthcare utilization metrics may be used to proactively identify at-risk patients for financial toxicity.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Every Woman Study™ 2018 - 13 hour(s) ago
The Study Guided by an international expert advisory panel, the World Ovarian Cancer Coalition undertook the Every Woman Study™ in 2018. The Study included the largest-ever global survey of women with the disease. The objective was simple: to address the evidence gap and identify a way forward to e
Source: worldovariancancercoalition.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Cancer Tomorrow - 13 hour(s) ago
Cancer Tomorrow – Predictions of the future cancer incidence and mortality burden worldwide up until 2050
Source: gco.iarc.frCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Awareness and Early Detection Remain Key Issues in Ovarian Cancer - 13 hour(s) ago
Vaidehi Mujumdar, MD, discusses updates in ovarian cancer for 2024 World Ovarian Cancer Day.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Health Canada Approves Goserelin Acetate for High-Risk, ER+ Early and Advanced Breast Cancer - 14 hour(s) ago
Health Canada has approved an sNDA for goserelin acetate 10.8 mg every 12 weeks for ER-positive early breast cancer with a high risk of recurrence or advanced breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Treatment with acalabrutinib-based regimens led to long-term benefits in patients with higher-risk CLL, across all lines of therapy.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Awareness and Early Detection Remain Key Issues in Ovarian Cancer - 16 hour(s) ago
Vaidehi Mujumdar, MD, discusses updates in ovarian cancer for 2024 World Ovarian Cancer Day.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2SLS009 Plus Venetoclax/Azacitidine Produces Responses in R/R AML, Including ASXL1+ Disease - 18 hour(s) ago
SLS009 plus venetoclax and azacitidine elicited responses in patients with relapsed/refractory AML, particularly in those harboring ASXL1 mutations.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Final USPSTF Recommendation Statement Advises Women Begin Receiving Mammograms at 40 Years Old - 19 hour(s) ago
The United States Preventive Services Task Force final breast cancer screening recommendation statement advises that women aged 40 begin biennial screening.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
A chemotherapy-free regimen of trastuzumab plus pertuzumab generated a strong 3-year iDFS rate in patients with HER2-positive early breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
The cost of cancer care can be debilitating. The cost of OC treatment, including medical expenses, medications, and supportive care services, can place a significant financial burden on patients and their families. @jubileebrown @VeeMuj #WOCD2024 https://t.co/esQ8X2pzNw